2025
SJR Q2
JCR Q3 · 2,3
60 matched articles
SCIE
Journal detail
Immunological Investigations
- Publisher
- Taylor & Francis Group LLC Philadelphia
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
0882013915324311
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,653
- Quartile Q2
- H-Index 60
- Cites/doc 2,41
- Docs (3y) 289
- Cites (3y) 762
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,3
- 5Y JIF 2,3
- JCI 0,59
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Immunology Q3
- Medicine (miscellaneous) Q2
Areas
- Immunology and Microbiology
- Medicine
WoS categories
- Immunology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,653 | 2,3 | 2,3 | 0,59 | Q3 | 60 |
| 2024 | Q2 | Q3 | 0,624 | 2,4 | 2,2 | 0,51 | Q3 | 56 |
| 2023 | Q2 | Q3 | 0,654 | 2,9 | 2,6 | 0,45 | Q3 | 56 |
| 2022 | Q2 | Q4 | 0,596 | 2,8 | 2,6 | 0,52 | Q3 | 56 |
| 2021 | Q2 | Q4 | 0,57 | 3 | 2,9 | 0,52 | Q3 | 56 |
| 2020 | Q2 | Q3 | 0,737 | 3,7 | 3,3 | 0,82 | Q2 | 56 |
| 2019 | Q2 | Q3 | 0,797 | 2,5 | 2,3 | 0,72 | Q2 | 56 |
| 2018 | — | Q3 | — | 2,7 | 2,1 | 0,67 | Q3 | — |
| 2017 | Q2 | Q3 | 0,74 | 2,6 | 2 | 0,62 | Q3 | 56 |
| 2016 | Q2 | Q4 | 0,677 | 1,8 | 1,8 | — | — | 56 |
| 2015 | Q2 | Q4 | 0,792 | 1,8 | 1,9 | — | — | 56 |
| 2014 | Q2 | Q4 | 0,711 | 2 | 1,6 | — | — | 56 |
| 2013 | Q2 | Q4 | 0,756 | 1,9 | 1,6 | — | — | 56 |
| 2012 | Q2 | Q4 | 0,578 | 1,7 | 1,5 | — | — | 56 |
| 2011 | Q2 | Q4 | 0,489 | 1,2 | 1,5 | — | — | 56 |
| 2010 | Q2 | Q4 | 0,43 | 1,3 | 1,4 | — | — | 56 |
| 2009 | — | Q4 | — | 1,5 | 1,4 | — | — | — |
| 2008 | — | Q4 | — | 1,8 | 1,5 | — | — | — |
| 2007 | — | Q4 | — | 1,5 | 1,4 | — | — | — |
| 2006 | — | Q4 | — | 1,3 | — | — | — | — |
| 2005 | — | Q4 | — | 0,9 | — | — | — | — |
| 2004 | — | Q4 | — | 1,2 | — | — | — | — |
| 2003 | — | Q4 | — | 0,9 | — | — | — | — |
| 2002 | — | Q3 | — | 1,6 | — | — | — | — |
| 2001 | — | Q3 | — | 1,2 | — | — | — | — |
| 2000 | — | Q4 | — | 0,6 | — | — | — | — |
| 1999 | — | Q3 | — | 1,1 | — | — | — | — |
| 1998 | — | Q3 | — | 1 | — | — | — | — |
| 1997 | — | Q4 | — | 0,8 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | IMMUNOLOGY | SCIE | Q3 | Q3 | 135/183 |
| 2024 | IMMUNOLOGY | SCIE | Q3 | Q3 | 129/183 |
| 2023 | IMMUNOLOGY | SCIE | Q3 | Q3 | 108/181 |
| 2022 | IMMUNOLOGY | SCIE | Q4 | Q3 | 122/161 |
| 2021 | IMMUNOLOGY | SCIE | Q4 | Q3 | 127/162 |
| 2020 | IMMUNOLOGY | SCIE | Q3 | Q2 | 98/162 |
| 2019 | IMMUNOLOGY | SCIE | Q3 | Q2 | 111/159 |
| 2018 | IMMUNOLOGY | SCIE | Q3 | Q3 | 101/158 |
| 2017 | IMMUNOLOGY | SCIE | Q3 | Q3 | 98/155 |
| 2016 | IMMUNOLOGY | SCIE | Q4 | — | 121/151 |
| 2015 | IMMUNOLOGY | SCIE | Q4 | — | 125/151 |
| 2014 | IMMUNOLOGY | SCIE | Q4 | — | 113/148 |
| 2013 | IMMUNOLOGY | SCIE | Q4 | — | 115/144 |
| 2012 | IMMUNOLOGY | SCIE | Q4 | — | 113/137 |
| 2011 | IMMUNOLOGY | SCIE | Q4 | — | 121/139 |
| 2010 | IMMUNOLOGY | SCIE | Q4 | — | 113/134 |
| 2009 | IMMUNOLOGY | SCIE | Q4 | — | 110/128 |
| 2008 | IMMUNOLOGY | SCIE | Q4 | — | 95/121 |
| 2007 | IMMUNOLOGY | SCIE | Q4 | — | 96/119 |
| 2006 | IMMUNOLOGY | SCIE | Q4 | — | 96/117 |
| 2005 | IMMUNOLOGY | SCIE | Q4 | — | 101/115 |
| 2004 | IMMUNOLOGY | SCIE | Q4 | — | 92/111 |
| 2003 | IMMUNOLOGY | SCIE | Q4 | — | 96/114 |
| 2002 | IMMUNOLOGY | SCIE | Q3 | — | 77/119 |
| 2001 | IMMUNOLOGY | SCIE | Q3 | — | 81/114 |
| 2000 | IMMUNOLOGY | SCIE | Q4 | — | 101/116 |
| 1999 | IMMUNOLOGY | SCIE | Q3 | — | 84/115 |
| 1998 | IMMUNOLOGY | SCIE | Q3 | — | 88/120 |
| 1997 | IMMUNOLOGY | SCIE | Q4 | — | 90/117 |